How Tricentis and Tx3 are bridging the gap between regulatory compliance and modern software delivery
Tricentis and Tx3 executives share the details of Tricentis’ just-announced acquisition of Tx3, which extends our industry-leading continuous testing portfolio with automated digital validation for life sciences and healthcare organizations.
In this webinar, you will learn how the two companies are coming together to enable FDA-regulated organizations to modernize application delivery and reduce risk by integrating digital validation and compliance management with Agile and DevOps workflows. Our executives will share what this acquisition means for our customers and the life sciences industry, as well as how you can leverage Tx3 to modernize your software delivery processes, while dramatically reducing the time and expense associated with traditional validation methods.
Watch this webinar to learn how Tx3: